Rani Therapeutics Holdings, Inc. (RANI)
1.365
-0.02
(-1.80%)
USD |
NASDAQ |
Jan 20, 16:00
1.35
-0.02
(-1.10%)
After-Hours: 17:39
Rani Therapeutics Holdings Total Liabilities (Quarterly): 22.11M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Exelixis, Inc. | 662.85M |
| Eli Lilly & Co. | 91.08B |
| Olema Pharmaceuticals, Inc. | 44.96M |
| CEL-SCI Corp. | 12.20M |
| AIM ImmunoTech, Inc. | 11.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.14M |
| Shareholders Equity (Quarterly) | -7.86M |
| Debt to Equity Ratio | -2.233 |
| Current Ratio | 0.2588 |
| Net Debt Paydown Yield | 14.77% |